When regulators request the history of a single batch, the clock starts immediately. In many cell therapy and biologics manufacturing environments, that request triggers a familiar response: teams pause their daily work and begin gathering records from multiple sources. Batch records from storage. Scheduling logs from separate systems. Freezer records from another application. Deviation logs stored in spreadsheets. Signature chains verified manually. What should be a straightforward review often becomes a multi-week coordination effort. Over time, our team has observed that the real challenge is not documentation itself. It is fragmentation. The Hidden Burden of Fragmented GMP Systems Cell and …